✦ LIBER ✦

Plasma Levels of Monocyte Chemotactic Protein 3 and Beta-Nerve Growth Factor Increase with Amnestic Mild Cognitive Impairment

✍ Scribed by Lee, Kang Soo; Chung, Ji Hyung; Lee, Kyung Hye; Shin, Min-Jeong; Oh, Byoung Hoon; Lee, Soo Hyung; Hong, Chang Hyung

Book ID: 109846460
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 209 KB
Volume: 6
Category: Article
ISSN: 1672-7681
DOI: 10.1038/cmi.2009.20

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.5.b.002 Plasma levels of monocyte chem

P.5.b.002 Plasma levels of monocyte chemotactic protein 3 and beta-nerve growth factor increase in patients with amnestic mild cognitive impairment (MCI)

✍ S. Park; B. Lee 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 190 KB

P2-261 Plasma levels of amyloid beta-pro

P2-261 Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment

✍ Giliberto, Luca; Assini, Andrea; Cammarata, Sergio; Colucci, Monica; Borghi, Rob 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Plasma levels of lipocalin 2 and chitina

Plasma levels of lipocalin 2 and chitinase 3-like 1 protein in patients with amnestic mild cognitive impairment and Alzheimer's disease

✍ Kang, Kyunghun; Lee, Ho-Won; Yoon, Uicheul 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Decreased levels of PSD95 and two associ

Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Aβ, and neurodegeneration in a prodromal stage of Alzheimer's disease

✍ Rukhsana Sultana; William A. Banks; D. Allan Butterfield 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

## Abstract Alzheimer's disease (AD) is the most common form of dementia and is pathologically characterized by senile plaques, neurofibrillary tangles, synaptic disruption and loss, and progressive neuronal deficits. The exact mechanism(s) of AD pathogenesis largely remain unknown. With advances i